Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06113237 · ClinicalTrials.gov registry record
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
A clinical trial of Pregnancy and Maternal Complications, sponsored by Jazz Pharmaceuticals.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06113237: Recruiting study of Pregnancy and Maternal Complications, sponsored by Jazz Pharmaceuticals.
NCT06113237 is a study of Pregnancy and Maternal Complications that is actively recruiting participants, run by Jazz Pharmaceuticals. The registered enrollment target is 50 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06113237, a study of Pregnancy and Maternal Complications, is actively recruiting participants, sponsored by Jazz Pharmaceuticals.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life.
Primary Outcome
Rate of Major congenital malformation (MCM) identified in the developing neonate and infant through 12 months of age
Conditions Studied
Interventions
- DRUG Epidiolex
Study Locations (1)
West Virginia
- United Biosource LLC - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2033-08-31 |
What NCT06113237 shows while recruiting
NCT06113237 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower).
The record links to 4 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Epidiolex is the first listed.
NCT06113237 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT06113237 about?
NCT06113237 is a clinical study titled "Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy". The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life.
What is the current status of trial NCT06113237?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-08-05. Estimated completion is 2033-08-31.
What conditions does trial NCT06113237 study?
This clinical trial studies the following conditions: Pregnancy, Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse.
What interventions are being tested in trial NCT06113237?
The interventions under investigation include: Epidiolex (DRUG).
Who is sponsoring clinical trial NCT06113237?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06113237 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06113237's enrollment target sits among peer trials
50 152nd of 191 higher than 34 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI